Your browser doesn't support javascript.
loading
Seroprevalence of hepatitis B and C in the Western Brazilian Amazon region (Rio Branco, Acre): a pilot study carried out during a hepatitis B vaccination program
Tavares-Neto, J; Almeida, D; Soares, M. C; Uchoa, R; Viana, S; Darub, R; Farias, E; Rocha, G; Vitvitski, L; Paraná, R.
Afiliación
  • Tavares-Neto, J; University of Bahia. Group for the Study of Viral Hepatitis. Salvador. BR
  • Almeida, D; University of Bahia. Group for the Study of Viral Hepatitis. Salvador. BR
  • Soares, M. C; Evandro Chagas Institute. Belém. BR
  • Uchoa, R; Acre State Public Health Program. Rio Branco. BR
  • Viana, S; Acre State Public Health Program. Rio Branco. BR
  • Darub, R; Acre State Public Health Program. Rio Branco. BR
  • Farias, E; Acre State Public Health Program. Rio Branco. BR
  • Rocha, G; Acre State Public Health Program. Rio Branco. BR
  • Vitvitski, L; Institut National de la Santé et de la Recherche Médicale. Lyon. FR
  • Paraná, R; University of Bahia. Group for the Study of Viral Hepatitis. Salvador. BR
Braz. j. infect. dis ; Braz. j. infect. dis;8(2): 133-139, Apr. 2004. mapas, tab
Article en En | LILACS | ID: lil-365406
Biblioteca responsable: BR1.1
ABSTRACT
In 1999, on the occasion of the application of the first vaccine dose during the state vaccination campaign against hepatitis B virus (HBV), 390 individuals from the town of Rio Branco, Acre, aged two or more years were selected for the determination of the seroprevalence of HBV and HCV. HBV markers (HBsAg, anti-HBs, and anti-HBc IgG) were determined on this occasion and anti-HBs antibodies were also assessed 30 days after the third vaccine dose. At the time of vaccination, 39 percent of the individuals were still susceptible to HBV, while 61 percent presented serologic evidence of previous HBV contact or previous vaccination. The individuals with previous HBV contact were significantly older (p<0.001) than those without HBV markers. Of the 192 individuals who returned for reexamination, 30 days after the third dose, 158 (82.3 percent) had received three vaccine doses, and only 60 (31.2 percent) belonged to the group without HBV markers. In these individuals, the seroconversion rate after the third dose was 92 percent (55/60). In conclusion, we found considerable HBV in this population, indicating the need for pursuing the immunization programs. We also found high rates of vaccination coverage in the Western Brazilian Amazon region.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Hepatitis C / Vacunas contra Hepatitis B / Hepatitis B Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2004 Tipo del documento: Article / Project document País de afiliación: Brasil / Francia Pais de publicación: Brasil
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Hepatitis C / Vacunas contra Hepatitis B / Hepatitis B Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2004 Tipo del documento: Article / Project document País de afiliación: Brasil / Francia Pais de publicación: Brasil